| Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research NA Turner, BK Sharma-Kuinkel, SA Maskarinec, EM Eichenberger, ... Nature Reviews Microbiology 17 (4), 203-218, 2019 | 1441 | 2019 |
| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 12 (1), 2349, 2021 | 336 | 2021 |
| Use of letermovir as salvage therapy for drug-resistant cytomegalovirus retinitis N Turner, A Strand, DS Grewal, G Cox, S Arif, AW Baker, EK Maziarz, ... Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 02337-18, 2019 | 86 | 2019 |
| WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4 Q Liu, H Chen, T Ojode, X Gao, S Anaya-O'Brien, NA Turner, J Ulrick, ... Blood, The Journal of the American Society of Hematology 120 (1), 181-189, 2012 | 80 | 2012 |
| SARS-CoV-2 infections among children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) study JH Hurst, SM Heston, HN Chambers, HM Cunningham, MJ Price, ... medRxiv, 2020 | 65 | 2020 |
| A novel relaxase homologue is involved in chromosomal DNA processing for type IV secretion in Neisseria gonorrhoeae W Salgado‐Pabón, S Jain, N Turner, C Van Der Does, JP Dillard Molecular microbiology 66 (4), 930-947, 2007 | 57 | 2007 |
| B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury MG DomBourian, NA Turner, TA Gerovac, R Vemuganti, GS Miranpuri, ... Spine 31 (24), 2778-2782, 2006 | 57 | 2006 |
| Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents C Garrido, JH Hurst, CG Lorang, JN Aquino, J Rodriguez, TS Pfeiffer, ... JCI insight 6 (17), 2021 | 52 | 2021 |
| Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia SA Maskarinec, LP Park, F Ruffin, NA Turner, N Patel, EM Eichenberger, ... Clinical Microbiology and Infection 26 (7), 904-910, 2020 | 48 | 2020 |
| Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats S Rajpal, TA Gerovac, NA Turner, JI Tilghman, BK Allcock, ... Journal of Neurosurgery: Spine 6 (5), 420-424, 2007 | 37 | 2007 |
| Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE randomized clinical trial AM Copaescu, S Vogrin, F James, KYL Chua, MT Rose, J De Luca, ... JAMA internal medicine 183 (9), 944-952, 2023 | 35 | 2023 |
| Association of Black race with physical and chemical restraint use among patients undergoing emergency psychiatric evaluation CM Smith, NA Turner, NM Thielman, DS Tweedy, J Egger, JP Gagliardi Psychiatric Services 73 (7), 730-736, 2022 | 32 | 2022 |
| Variability in the management of adults with pulmonary nontuberculous mycobacterial disease G Abate, JT Stapleton, N Rouphael, B Creech, JE Stout, HM El Sahly, ... Clinical infectious diseases 72 (7), 1127-1137, 2021 | 28 | 2021 |
| Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group ALV Hobbs, N Turner, I Omer, MK Walker, RM Beaulieu, M Sheikh, ... Infection Control & Hospital Epidemiology 42 (12), 1464-1472, 2021 | 27 | 2021 |
| Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network 2 Nicholas A. Turner, MD, MHSc1, PD Steven C. Grambow, ... JAMA Network Open 2 (10), e1914149, 2019 | 27 | 2019 |
| Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial NA Turner, S Zaharoff, H King, S Evans, T Hamasaki, T Lodise, ... Trials 23 (1), 407, 2022 | 26 | 2022 |
| Evaluation of a pharmacist-led penicillin allergy assessment program and allergy delabeling in a tertiary care hospital NA Turner, R Wrenn, C Sarubbi, R Kleris, PL Lugar, C Radojicic, ... JAMA Network Open 4 (5), e219820-e219820, 2021 | 25 | 2021 |
| Novel and emerging sources of Clostridioides difficile infection NA Turner, BA Smith, SS Lewis PLoS pathogens 15 (12), e1008125, 2019 | 25 | 2019 |
| Severe acute respiratory syndrome coronavirus 2 infections among children in the biospecimens from respiratory virus-exposed kids (BRAVE Kids) study JH Hurst, SM Heston, HN Chambers, HM Cunningham, MJ Price, ... Clinical Infectious Diseases 73 (9), e2875-e2882, 2021 | 24 | 2021 |
| Hospital infection control: Clostridioides difficile NA Turner, DJ Anderson Clinics in colon and rectal surgery 33 (02), 098-108, 2020 | 24 | 2020 |
